Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus

Antimicrob Agents Chemother. 1994 Oct;38(10):2495-7. doi: 10.1128/AAC.38.10.2495.

Abstract

For 212 oropharyngeal isolates of Candida albicans, the fluconazole MICs for 50 and 90% of strains tested were 0.5 and 16 micrograms/ml, respectively, and those of itraconazole were 0.05 and 0.2 micrograms/ml, respectively. Of 16 isolates for which fluconazole MICs were > 64 micrograms/ml, itraconazole MICs for 14 were < or = 0.8 micrograms/ml and for 2 were > 6.4 micrograms/ml. Most fluconazole-resistant strains remained susceptible to itraconazole; whether itraconazole will prove effective for refractory thrush remains to be shown.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / microbiology*
  • Candida albicans / drug effects*
  • Drug Resistance, Microbial
  • Fluconazole / pharmacology*
  • Humans
  • Itraconazole / pharmacology*
  • Microbial Sensitivity Tests
  • Oropharynx / microbiology*

Substances

  • Itraconazole
  • Fluconazole